Author Question: You are a beautician about to apply a reducing agent to a customer with fine hair who wants to have ... (Read 106 times)

mrsjacobs44

  • Hero Member
  • *****
  • Posts: 500
You are a beautician about to apply a reducing agent to a customer with fine hair who wants to have his hair curly. Should the reducing agent be regular strength, concentrated, or diluted?
 
  A) regular strength
  B) concentrated, because in thin hair each strand is made of fewer cysteine amino acids
  C) dilute, so as not to cause the hair to fall apart completely
  D) concentrated, in order to add more disulfide cross-linking

Question 2

How are photovoltaic cells different from many other forms of solar energy?
 
  A) Light is converted directly to electricity.
  B) Light is converted into heat and then into steam.
  C) Light is passively converted into heat.
  D) Light is reflected and the coolness of the shade is used to provide a temperature differential.
  E) none of the above



izzat

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

C

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library